Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04515095 · ClinicalTrials.gov registry record · NA

Water-only Fasting in the Treatment of Hypertension Patients

A NA study of Hypertension, sponsored by TrueNorth Health Foundation.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04515095: Completed NA study of Hypertension, sponsored by TrueNorth Health Foundation.

NCT04515095 is a NA study of Hypertension that has completed, run by TrueNorth Health Foundation. The registered enrollment target is 30 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04515095, a NA study of Hypertension, has completed, sponsored by TrueNorth Health Foundation.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This purpose of this study is to examine the safety and feasibility of water-only fasting to treat hypertensive patients.

Primary Outcome

Adverse events will be identified through participant interviews and medical record review

Conditions Studied

Interventions

  • OTHER Water-only Fasting

Study Locations (1)

California

  • TrueNorth Health Center - Santa Rosa

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-08-16
Est. Completion 2022-12-01
Phase NA
TrueNorth Health Foundation

3 total trials

What the finished NCT04515095 record still lists

NCT04515095 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Water-only Fasting is the first listed.

NCT04515095 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04515095 about?

NCT04515095 is a clinical study titled "Water-only Fasting in the Treatment of Hypertension Patients". This purpose of this study is to examine the safety and feasibility of water-only fasting to treat hypertensive patients.

What is the current status of trial NCT04515095?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-08-16. Estimated completion is 2022-12-01.

What conditions does trial NCT04515095 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT04515095?

The interventions under investigation include: Water-only Fasting (OTHER).

Who is sponsoring clinical trial NCT04515095?

This trial is sponsored by TrueNorth Health Foundation, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04515095 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04515095's enrollment target sits among peer trials

30 408th of 470 higher than 54 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04515095, the US trial registry maintained by the National Library of Medicine. NCT04515095 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.